NCT03711032 · Interventional trial
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
Overall registry status Active not recruiting
Phase 3
Conditions High-risk Non-muscle Invasive Bladder Cancer
Delaware Valley sites
- MidLantic Urology ( Site 1071) · Bala-Cynwyd, PA · Montgomery County
- University of Pennsylvania ( Site 1088) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory